China NMPA Inspection - Shanxi Wanglong Pharmaceutical Group Co., Ltd. - January 20, 2017
China NMPA unannounced inspection for Shanxi Wanglong Pharmaceutical Group Co., Ltd. published January 20, 2017. Shanxi Wanglong Pharmaceutical Group Co., Ltd. was subject to an unannounced inspection by the State Food and Drug Administration on December 12-13, 2
One-time purchase from the GKS catalog. Lifetime access in your library. Single documents and full company profiles available. All sales final.
China NMPA unannounced inspection for Shanxi Wanglong Pharmaceutical Group Co., Ltd. published January 20, 2017. Shanxi Wanglong Pharmaceutical Group Co., Ltd. was subject to an unannounced inspection by the State Food and Drug Administration on December 12-13, 2
Access our comprehensive regulatory intelligence platform to analyze patterns, track compliance trends, and stay ahead of regulatory changes.
Inspection Date
Unknown Date
Product Type
Drugs
ID: 3511f9c3-c4f3-4cb1-9ffb-2eb1a396357c
View on DashboardTransform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust GKS for their regulatory compliance needs.
Try KeyPedia Today
Explore our real use cases and discover our features in depth.
Subscribe to our newsletter
Get the latest updates and insights delivered to your inbox